Sionna Therapeutics, Inc.
General ticker "SION" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $1.7B (TTM average)
Sionna Therapeutics, Inc. does not follow the US Stock Market performance with the rate: -23.9%.
Estimated limits based on current volatility of 4.0%: low 3.79$, high 4.11$
Factors to consider:
- Earnings expected soon, date: 2026-11-04 bmo
- Total employees count: 59 (+43.9%) as of 2025
- Company does not operate outside US (retrieved using AI)
- Top business risk factors: Limited operating history, Clinical trial failure, Regulatory and compliance, Supply chain disruptions, Insufficient capital
Short-term SION quotes
Long-term SION plot
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $0.00MM |
| Operating Expenses | $50.33MM | $70.56MM | $88.98MM |
| Operating Income | $-50.33MM | $-70.56MM | $-88.98MM |
| Non-Operating Income | $3.07MM | $8.87MM | $13.71MM |
| R&D Expense | $40.63MM | $57.29MM | $60.26MM |
| Income(Loss) | $-47.26MM | $-61.69MM | $-75.27MM |
| Net Income(Loss)* | $-47.26MM | $-61.69MM | $-75.27MM |
| Stockholders Equity | $-114.88MM | $-163.71MM | $306.83MM |
| Assets | $51.95MM | $185.75MM | $325.95MM |
| Operating Cash Flow | $-43.70MM | $-52.79MM | $-66.30MM |
| Capital expenditure | $1.12MM | $0.03MM | $0.38MM |
| Investing Cash Flow | $27.35MM | $-126.91MM | $-118.75MM |
| Financing Cash Flow | $0.03MM | $178.97MM | $205.71MM |
| Earnings Per Share** | $-1.07 | $-1.40 | $-1.88 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.